Citizens Jmp Downgrades Option Care Health (NASDAQ:OPCH) to Hold

Option Care Health (NASDAQ:OPCH) was downgraded by analysts at Citizens Jmp from a “market outperform” rating to a “hold” rating in a report issued on Wednesday, Marketbeat.com reports.

OPCH has been the subject of several other research reports. Weiss Ratings upgraded shares of Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and increased their price objective for the company from $28.00 to $32.05 in a report on Tuesday. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a report on Tuesday, September 22nd. Truist Financial set a $32.05 price objective on Option Care Health in a research report on Wednesday. Finally, Barrington Research reissued a “market perform” rating on shares of Option Care Health in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Hold” and an average target price of $29.70.

Option Care Health Price Performance

OPCH stock opened at $31.01 on Wednesday. The company has a 50 day simple moving average of $23.92 and a 200 day simple moving average of $23.57. The stock has a market cap of $4.64 billion, a price-to-earnings ratio of 23.32, a P/E/G ratio of 1.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the business posted $0.41 EPS. Option Care Health’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Research analysts anticipate that Option Care Health will post 1.7 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Arrowstreet Capital Limited Partnership lifted its stake in Option Care Health by 6.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after acquiring an additional 247,118 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Option Care Health by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after buying an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP grew its holdings in shares of Option Care Health by 20.0% in the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after acquiring an additional 600,000 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. bought a new stake in Option Care Health during the first quarter worth $70,287,000. Finally, Bank of America Corp DE grew its stake in Option Care Health by 14.6% in the 1st quarter. Bank of America Corp DE now owns 1,945,015 shares of the company’s stock valued at $52,360,000 after purchasing an additional 247,766 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for approximately $5.8 billion, providing a clear near-term valuation catalyst and largely explaining the sharp rally in OPCH shares. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Unusually heavy call-option activity, with 5,219 calls purchased versus typical volume of 281, indicates heightened bullish and deal-related speculation. However, options activity is not a guarantee that the transaction will close.
• Neutral Sentiment: JPMorgan reaffirmed its “neutral” rating while raising its price target to $33, and Citizens JMP and Barrington Research maintained “market perform” ratings. These views suggest limited fundamental upside beyond the cash offer absent a competing bid.
• Neutral Sentiment: Truist downgraded Option Care Health from “strong buy” to “hold,” likely reflecting the reduced upside after the buyout announcement rather than a deterioration in the company’s operating performance.
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values OPCH and whether insiders may receive benefits unavailable to public shareholders. Such reviews could increase headline risk or delay the transaction, although they do not by themselves indicate that the deal will fail. Ademi LLP OPCH Shareholder Alert

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.